Back

A defined cytokine regimen drives durable cardioprotection and fibrosis reversal in experimental heart failure

19 June 2026 (15:30 - 16:15)
Organised by: Logo
Congress Presentation Part of: A wider view in cardio-oncology research Cardio-Oncology Delegates Premium Access ESC Cardio-Oncology 2026 Council of Cardio-Oncology

About the speaker

Photo
Mrs Laris Achlaug

Technion - Israel Institute of Technology, Haifa (Israel)

5 More presentations in this session

Presentation thumbnail
Metabolomic phenotype of heart failure in cardio-oncology patients
Doctor Y. Belenkov (Moscow, RU)
Abstract Slides
Presentation thumbnail
Impairment of the DNA damage response pathway as a potential contributor towards peripartum cardiomyopathy
Mr T. Gausepohl (Hannover, DE)
Abstract Slides
Presentation thumbnail
Clonal hematopoiesis of indeterminate potential risk score for predicting clinical outcome in patients with heart failure with preserved ejection fraction
Assistant Professor M. Kim (Yongin, KR)
Abstract Slides
Presentation thumbnail
Exploring the mechanisms mediating the inverse association between heart failure and prostate cancer risk: a nested case-control study
Doctor S. Gomez Ochoa (Heidelberg, DE)
Abstract Slides
Presentation thumbnail
The ICOS-ICOSL co-stimulatory axis in cardiac fibrosis: distinct pathological outcomes following receptor vs. ligand inhibition
Mr Z. Hegedus (Budapest, HU)
Abstract Slides

Access the full session

Session thumbnail
A wider view in cardio-oncology research

The Event

Event poster

ESC Cardio-Oncology 2026

19 June 2026 15:30 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources